The MPM market is expanding due to increasing asbestos exposure, improved diagnostic techniques, and advancements in targeted therapies. Companies like Bristol-Myers Squibb, Merck, and ImmunoGen are developing innovative treatments, including immunotherapies and combination therapies. These developments aim to enhance patient outcomes and address the unmet medical needs in MPM treatment. Access Market Report: https://shorturl.at/Yg2cZ